Converge Bio vs Scala Biodesign
Converge Bio vs Scala Biodesign, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Converge Bio is on 56/100 and Scala Biodesign on 56/100.
Where each one leads
Converge Bio
- domain rating: 28/100 against 23/100
- headcount: 51 against 30
- headcount growth: +220.3% against +49.4%
Scala Biodesign
- funding raised: $21.5M against $5.5M
At a glance
| Measure | Converge Bio | Scala Biodesign |
|---|---|---|
| What it is | Computational platform using LLMs trained on biological and chemical data for drug discovery. | Designs proteins with superior properties using computational analysis, evolutionary insights, and AI. |
| Category | Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical | Life Sciences, Biotech, Protein, AI-Driven Protein Design |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2023 | 2021 |
| Headquarters | San Francisco, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Converge Bio | Scala Biodesign |
|---|---|---|
| Employees | 51 | 30 |
| Headcount growthLast 12 months | +220.3% | +49.4% |
| Total funding | $5.5M | $21.5M |
| Latest round | Seed | Series A |
| LinkedIn followers | 6,830 | 5,945 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Converge Bio | Scala Biodesign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 56/100 |
| Traction | 51/100 | 52/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 36/100 | 34/100 |
| Quality | 62/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 28/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Converge Bio | Scala Biodesign |
|---|---|---|
| CMS | Framer | Wix |
| Analytics | Google Tag Manager, Microsoft Clarity | Linkedin Insight |
| Open source | Yes | Yes |
| Self-hostable | Yes | No |
Converge Bio vs Scala Biodesign: common questions
Which is better, Converge Bio or Scala Biodesign?
Both score the same on our 0-100 rating, so the choice comes down to the 23 data points in the tables above rather than overall company strength.
How do Converge Bio and Scala Biodesign compare on the numbers?
Converge Bio leads on domain rating (28/100 against 23/100), headcount (51 against 30), headcount growth (+220.3% against +49.4%). Scala Biodesign leads on funding raised ($21.5M against $5.5M).
Read the full Converge Bio review and pricing or the Scala Biodesign review and pricing. You can also browse other Converge Bio alternatives we track.